Showing results (541-550 of 671) with videos related to
Sort By:
Pageof 68
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.Lung Cancer (Amsterdam, Netherlands)|August 16, 2022
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironmentNeal Akhave, Jiexin Zhang, Erin Bayley, et al.Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.Cancer Biology & Therapy|September 17, 2009
Amplification of chromosomal segment 4q12 in non-small cell lung cancerAlex H Ramos, Amit Dutt, Craig Mermel, et al.Science (New York, N.Y.)|October 11, 2014
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencingJianjun Zhang, Junya Fujimoto, Jianhua Zhang, et al.Oncotarget|October 20, 2018
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of <i>RICTOR/KRAS</i>-altered non-small cell lung cancerDennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, et al.Nature Communications|May 10, 2023
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinomaJose A Karam, Pavlos Msaouel, Cara L Haymaker, et al.Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2017
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung CancerTina Cascone, Li Xu, Heather Y Lin, et al.Plos One|June 21, 2013
Fibulin-2 is a driver of malignant progression in lung adenocarcinomaBrandi N Baird, Mark J Schliekelman, Young-Ho Ahn, et al.Pageof 68